Tay BQ, Wright Q, Ladwa R, Perry C, Leggatt G, Simpson F, Wells JW, Panizza BJ, Frazer IH, Cruz JLG. Evolution of cancer vaccines—challenges, achievements, and future directions. Vaccines. 2021;9(5):535.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin MJ, Svensson-Arvelund J, Lubitz GS, Marabelle A, Melero I, Brown BD, Brody JD. Cancer vaccines: the next immunotherapy frontier. Nat Cancer. 2022;3(8):911–26.

Article  CAS  PubMed  Google Scholar 

Saxena M, van der Burg SH, Melief CJM, Bhardwaj N. Therapeutic cancer vaccines. Nat Rev Cancer. 2021;21(6):360–78.

Article  CAS  PubMed  Google Scholar 

Rojas LA, Sethna Z, Soares KC, Olcese C, Pang N, Patterson E, Lihm J, Ceglia N, Guasp P, Chu A, Yu R, Chandra AK, Waters T, Ruan J, Amisaki M, Zebboudj A, Odgerel Z, Payne G, Derhovanessian E, Müller F, Rhee I, Yadav M, Dobrin A, Sadelain M, Łuksza M, Cohen N, Tang L, Basturk O, Gönen M, Katz S, Do RK, Epstein AS, Momtaz P, Park W, Sugarman R, Varghese AM, Won E, Desai A, Wei AC, D’Angelica MI, Kingham TP, Mellman I, Merghoub T, Wolchok JD, Sahin U, Türeci Ö, Greenbaum BD, Jarnagin WR, Drebin J, O’Reilly EM, Balachandran VP. Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer. Nature. 2023;618(7963):144–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dranoff G. GM-CSF-based cancer vaccines. Immunol Rev. 2002;188:147–54.

Article  CAS  PubMed  Google Scholar 

Dranoff G, Jaffee E, Lazenby A, Golumbek P, Levitsky H, Brose K, Jackson V, Hamada H, Pardoll D, Mulligan RC. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci U S A. 1993;90(8):3539–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kumar A, Taghi Khani A, Sanchez Ortiz A, Swaminathan S. GM-CSF: a double-edged sword in cancer immunotherapy. Front Immunol. 2022;13:901277.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Clive KS, Tyler JA, Clifton GT, Holmes JP, Mittendorf EA, Ponniah S, Peoples GE. Use of GM-CSF as an adjuvant with cancer vaccines: beneficial or detrimental? Expert Rev Vaccines. 2010;9(5):519–25.

Article  CAS  PubMed  Google Scholar 

Le DT, Picozzi VJ, Ko AH, Wainberg ZA, Kindler H, Wang-Gillam A, Oberstein P, Morse MA, Zeh HJ, Weekes C, Reid T, Borazanci E, Crocenzi T, LoConte NK, Musher B, Laheru D, Murphy A, Whiting C, Nair N, Enstrom A, Ferber S, Brockstedt DG, Jaffee EM. Results from a phase IIb, randomized, multicenter study of GVAX pancreas and CRS-207 compared with chemotherapy in adults with previously treated metastatic pancreatic adenocarcinoma (ECLIPSE study). Clin Cancer Res. 2019;25(18):5493–502.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Soiffer RJ, Kooshesh KA, Ho V. Whole tumor cell vaccines engineered to secrete GM-CSF (GVAX). ImmunoMedicine. 2021. https://doi.org/10.1002/imed.1025.

Article  Google Scholar 

Fernandez E, Vernet R, Charrier E, Migliorini DM, Urwyler M, Belkouch MC, Von Rohr O, Saingier V, Ancrenaz V, Grandjean N, Lafferma E, Lavalliere E, Rubin O, Villard J, Grogg JN, Mach N. 762P personalized immunotherapy with encapsulated cell technology: feasibility, safety and efficacy results from the first-in-human clinical trial in advanced relapsing solid tumors. Ann Oncol. 2022;33:S891.

Article  Google Scholar 

Vernet R, Fernandez E, Migliorini D, Ancrenaz V, Charrier E, Belkouch MC, Von Rohr O, Urwyler M, De Vito C, Renaux J, Villard J, Rubin O, Grogg J, Mach N. A first-in-human phase I clinical study with MVX-ONCO-1, a personalized active immunotherapy, in patients with advanced solid tumors. Cancer Res Commun. 2024. https://doi.org/10.1158/2767-9764.CRC-24-0150.

Article  PubMed  PubMed Central  Google Scholar 

Mach N, Fernandez E, Vernet R, Vonrohr O, Urwyler M, Charrier E, Belkouch MC, Saingier V, Courtout F, De Vito C, Rubin O, Ancrenaz V, Grogg JN, Renaux J, Gysel K, Müller G, Brezina T, Rordorf T, Joerger M, Michielin OA. LBA46 SAKK 11/16, a phase IIa trial evaluating overall survival (OS) for recurrent/metastatic Head & neck squamous cell carcinoma (RMHNSCC) patients (pts) progressing after ≥ 1 line of systemic therapy, treated with MVX-ONCO-1, a novel, first in class cell encapsulation-based immunotherapy. Ann Oncol. 2023;34:S1286.

Article  Google Scholar 

A’Hern RP. Sample size tables for exact single-stage phase II designs. Stat Med. 2001;20(6):859–66.

Article  PubMed  Google Scholar 

Kieser M, Wirths M, Englert S, Kunz CU, Rauch G. OneArmPhaseTwoStudy : an R package for planning, conducting, and analysing single-arm phase II studies. J Stat Soft. 2017. https://doi.org/10.18637/jss.v081.i08.

Article  Google Scholar 

Zhang Z, Pan Q, Lu M, Zhao B. Intermediate endpoints as surrogates for outcomes in cancer immunotherapy: a systematic review and meta-analysis of phase 3 trials. EClinicalMedicine. 2023;63:102156.

Article  PubMed  PubMed Central  Google Scholar 

Hodi FS, Schmollinger JC, Soiffer RJ, Salgia R, Lynch T, Ritz J, Alyea EP, Yang J, Neuberg D, Mihm M, Dranoff G. ATP6S1 elicits potent humoral responses associated with immune-mediated tumor destruction. Proc Natl Acad Sci USA. 2002;99(10):6919–24.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Anderson KS, Erick TK, Chen M, Daley H, Campbell M, Colson Y, Mihm M, Zakka LR, Hopper M, Barry W, Winer EP, Dranoff G, Overmoyer B. The feasibility of using an autologous GM-CSF-secreting breast cancer vaccine to induce immunity in patients with stage II–III and metastatic breast cancers. Breast Cancer Res Treat. 2022;194(1):65–78.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Low JL, Chong WQ, Goh BC. Is abundance of B cells the best biomarker to predict immune checkpoint inhibitor response in head and neck squamous cell cancers? Ann Oncol. 2025;36:238.

Article  CAS  PubMed  Google Scholar 

Kim SS, Shen S, Miyauchi S, Sanders PD, Franiak-Pietryga I, Mell L, Gutkind JS, Cohen EEW, Califano JA, Sharabi AB. B cells improve overall survival in HPV-associated squamous cell carcinomas and are activated by radiation and PD-1 blockade. Clin Cancer Res. 2020;26(13):3345–59.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abdulla M, Traiki T, Vaali-Mohammed MA, El-Wetidy M, Alhassan N, Al-Khayal K, Zubaidi A, Al-Obeed O, Ahmad R. Targeting MUCL1 protein inhibits cell proliferation and EMT by deregulating β-catenin and increases irinotecan sensitivity in colorectal cancer. Int J Oncol. 2022;60(3):22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhatia R, Gautam SK, Cannon A, Thompson C, Hall BR, Aithal A, Banerjee K, Jain M, Solheim JC, Kumar S, Batra SK. Cancer-associated mucins: role in immune modulation and metastasis. Cancer Metastasis Rev. 2019;38(1–2):223–36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Q, Li X, Ren S, Cheng N, Zhao M, Zhang Y, Li J, Cai W, Zhao C, Cao W, Zhou C. Serum levels of the cancer-testis antigen POTEE and its clinical significance in non-small-cell lung cancer. PLoS ONE. 2015;10(4):e0122792.

Article  PubMed  PubMed Central  Google Scholar 

Hasegawa K, Fujii S, Matsumoto S, Tajiri Y, Kikuchi A, Kiyoshima T. Yap signaling induces PIEZO1 to promote oral squamous cell carcinoma cell proliferation. J Pathol. 2021;253(1):80–93.

Article  CAS  PubMed  Google Scholar 

Dudka I, Thysell E, Lundquist K, Antti H, Iglesias-Gato D, Flores-Morales A, Bergh A, Wikström P, Gröbner G. Comprehensive metabolomics analysis of prostate cancer tissue in relation to tumor aggressiveness and TMPRSS2-ERG fusion status. BMC Cancer. 2020;20(1):437.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Y, Li N, Zheng Y, Wang A, Yu C, Song Z, Wang S, Sun Y, Zheng L, Wang G, Liu L, Yi J, Huang Y, Zhang M, Bao Y, Sun L. KIAA1217 promotes epithelial-mesenchymal transition and hepatocellular carcinoma metastasis by interacting with and activating STAT3. IJMS. 2021;23(1):104.

Article  PubMed  PubMed Central  Google Scholar 

Choy CT, Wong CH, Chan SL. Embedding of genes using cancer gene expression data: biological relevance and potential application on biomarker discovery. Front Genet. 2019;9:682.

Article  PubMed  PubMed Central  Google Scholar